ZBH Zimmer Biomet Holdings
- 121.470
- +2.120+1.78%
Zimmer Biomet Holdings News
RBC Capital Sticks to Their Buy Rating for Zimmer Biomet Holdings (ZBH)
Zimmer Biomet Holdings Analyst Ratings
Zimmer Biomet Holdings Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Insmed (INSM) and Zimmer Biomet Holdings (ZBH)
Zimmer Biomet Holdings Analyst Ratings
Zimmer Biomet Holdings: Hold Rating Maintained Amid Innovative Growth Opportunities
Zimmer Biomet Holdings: Assessing the Impact of Stabilizing Prices on Market Performance
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH) and Antibe Therapeutics (OtherATBPF)
Zimmer Biomet Holdings Analyst Ratings
Sell Rating on Zimmer Biomet Holdings Amid Growth and Margin Challenges
Zimmer Biomet Holdings Analyst Ratings
Deutsche Bank Adjusts Zimmer Biomet Price Target to $140 From $147, Maintains Hold Rating
Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), BioNTech SE (BNTX) and Zimmer Biomet Holdings (ZBH)
Analysts Are Bullish on Top Healthcare Stocks: Zimmer Biomet Holdings (ZBH), Illumina (ILMN)
Analysts Offer Insights on Healthcare Companies: Alector (ALEC), Viking Therapeutics (VKTX) and Zimmer Biomet Holdings (ZBH)
Neutral Hold Rating for Zimmer Biomet Holdings Amidst Mixed Performance and Conservative Outlook
Zimmer Biomet Holdings: Hold Rating With Modest Growth and Marginal Pressure Anticipated
Needham Reaffirms Their Hold Rating on Zimmer Biomet Holdings (ZBH)
UBS Raises Zimmer Biomet Price Target to $105 From $99, Maintains Sell Rating
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $140
Analysis
Price Target
No Data
